期刊文献+

高效液相色谱法同时测定人血浆中齐多夫定、奈韦拉平浓度 被引量:8

Simultaneous Determination of Zidovudine and Nevirapine in Human Plasma by HPLC-UV
原文传递
导出
摘要 目的高效液相色谱法同时测定齐多夫定和奈韦拉平血浆中的浓度。方法色谱柱为岛津Shim-pack CLC-ODS(6mm×15cm,5μm)。流动相为乙腈-水(23∶77),流速1mL·min-1。紫外检测波长为260nm。柱温为室温。内标物(替加氟)与齐多夫定、奈韦拉平的保留时间分别为4.665,5.198和10.912min。结果齐多夫定、奈韦拉平的线性范围分别为0.025~10mg·L-1(r=0.9999)和0.05~10mg·L-1(r=0.9999),最低检测下限分别为0.025和0.05mg·L-1。样品溶液冻融稳定,日内精密度和日间精密度良好,回收率较高。结论采用HPLC-UV测定血浆中齐多夫定和奈韦拉平浓度,方法简便,结果准确可靠。 OBJECTIVE To establish a method for simultaneous determination of zidovudine(AZT) and nevirapine(NVP) in human plasma. METHODS The concentration of zidovudine and nevirapine were analyzed on a Shim-pack CLC-ODS (6 mm× 15 cm, 5 μm) with a mobile phase consisting ofwater-acetonitrile (23 : 77) at a flow rate of 1 mL·min^-1. The wavelength was 260 nm. The retention time of internal standard(tegafur), zidovudine and nevirapine were 4.665, 5.198 and 10.912 min, respectively. RESULTS The calibration curves of AZT and NVP were linear with the range of 0.025-10 mg·L^-1 (r=0.999 9) and 0.05-10 mg·L^-1 (r=0.999 9), and the limits of detection were 0.025 and 0.05 mg·L^-1, respectively. The average recoveries of AZT and NVP were both good. CONCLUSION The method was simple, practical and reliable to be used for the study of pharmacokinetics and pharmacodynamics.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第4期310-313,共4页 Chinese Pharmaceutical Journal
基金 北京市科委"艾滋病防治策略和综合防治研究"项目(D0906003040491)
关键词 齐多夫定 奈韦拉平 血药浓度 高效液相色谱法 zidovudine nevirapine plasma concentration HPLC
  • 相关文献

参考文献4

二级参考文献26

  • 1司雪峰,黄海龙,魏民,关琪,宋艳辉,马鹏飞,全宇,邢辉,邵一鸣.我国HIV-1感染者耐药突变的流行性研究[J].中华实验和临床病毒学杂志,2004,18(4):308-311. 被引量:45
  • 2朱余兵,邹健军,肖大伟,钱薇.国产齐多夫定片的血药浓度测定及相对生物利用度研究[J].中国药理学通报,2005,21(11):1404-1405. 被引量:2
  • 3Katy HPM,Ralph HR,Kim LRB,et al.Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease[J].Antimicrob Agents Chemother,1995,39(12):2732-2737.
  • 4Fan B,Stewart JT.Determination of zidovudine/lamivudine/ nevirapine in human plasma using ion-pair HPLC[J].J Pharm Biomed Anal,2002,28(5):903-908.
  • 5Nadal T,Ortuno J,Pascual JA.Rapid and sensitive determination of zidovudine and zidovudine glucuronide in human plasma by ion-pair high-performance liquid chromatography[J].JChromatogr A,1996,721 (1):127-137.
  • 6Drew RH, Weller S, Gallis HA, et al. Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulation in patients infected with human immunodeficiency virus [ J ] . Antimicrob Agents Chemother, 1989 ;33:1801 - 1803.
  • 7Schrive I,Plasse JC. Quantification of zidovudine and one of its metabolites in plasma and urine by solid - phase extraction and high - performance liquid chromatography[J]. J Chromatogr B, 1994; 657:233-237.
  • 8Yuen GJ, Lou Y, Thompson NF, et al. Abacavir/lamivudine/zidovudine as combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption[ J]. J Clin Pharmacol, 2001 ;41:277 -288.
  • 9Nebinger P, Koel M. Determination of serum zidovudine by ultrafiltration and high - performance liquid chromatography [ J ]. J Pharm Biomed Analysis, 1994 ;12:141 - 143.
  • 10Moore KHP, Raasch RH, Brouwer KLR, et al. Pharmacokinetics and bioavailability of ziodvudine and its glucuronidated metabolite in patients with hunan immunodeficiency virus infection and hepatic disease [ J ]. Antimicrob Agents Chemother, 1995 ;39:2732 - 2737.

共引文献7

同被引文献50

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部